F. Tabet

发表

Inhibition of inflammatory signaling pathways in 3T3‐L1 adipocytes by apolipoprotein A‐I

P. Barter, K. Rye, B. Cochran, 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Impact of Perturbed Pancreatic β-Cell Cholesterol Homeostasis on Adipose Tissue and Skeletal Muscle Metabolism

P. Barter, A. Tall, K. Rye, 2016, Diabetes.

Inhibition of Arthritis in the Lewis Rat by Apolipoprotein A-I and Reconstituted High-Density Lipoproteins

P. Barter, K. Rye, K. Ong, 2014, Arteriosclerosis, thrombosis, and vascular biology.

Plasma PCSK9 levels and clinical outcomes in the TNT (Treating to New Targets) trial: a nested case-control study.

P. Barter, J. Kastelein, S. Boekholdt, 2012, Journal of the American College of Cardiology.

Plasma PCSK9 levels and clinical outcomes in the TNT (Treating to New Targets) trial: a nested case-control study.

P. Barter, J. Kastelein, S. Boekholdt, 2012, Journal of the American College of Cardiology.

Lipid-Free Apolipoprotein A-I and Discoidal Reconstituted High-Density Lipoproteins Differentially Inhibit Glucose-Induced Oxidative Stress in Human Macrophages

P. Barter, A. Jenkins, R. Touyz, 2011, Arteriosclerosis, thrombosis, and vascular biology.

Effects of High-Density Lipoproteins on Pancreatic &bgr;-Cell Insulin Secretion

P. Barter, K. Rye, F. Tabet, 2010, Arteriosclerosis, thrombosis, and vascular biology.

High-density lipoproteins, inflammation and oxidative stress.

K. Rye, F. Tabet, 2009, Clinical science.

Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation.

E. Schiffrin, R. Touyz, G. Yao, 2003, Canadian journal of physiology and pharmacology.

Elevated plasma PCSK9 level is equally detrimental for patients with nonfamilial hypercholesterolemia and heterozygous familial hypercholesterolemia, irrespective of low-density lipoprotein receptor defects.

P. Barter, D. Blom, A. Marais, 2014, Journal of the American College of Cardiology.

Nonenzymatic Glycation Impairs the Antiinflammatory Properties of Apolipoprotein A-I

P. Barter, A. Jenkins, G. Dusting, 2010, Arteriosclerosis, thrombosis, and vascular biology.

Apolipoprotein A-I enhances insulin-dependent and insulin-independent glucose uptake by skeletal muscle

P. Barter, K. Rye, B. Cochran, 2019, Scientific Reports.

The 5A Apolipoprotein A-I Mimetic Peptide Displays Antiinflammatory and Antioxidant Properties In Vivo and In Vitro

P. Barter, A. Remaley, Ling Yan, 2010, Arteriosclerosis, thrombosis, and vascular biology.

The 5 A Apolipoprotein A-I Mimetic Peptide Displays Antiinflammatory and Antioxidant Properties In Vivo and In Vitro

P. Barter, A. Remaley, Ling Yan, 2010 .

Mitogen-activated protein kinase activation by hydrogen peroxide is mediated through tyrosine kinase-dependent, protein kinase C-independent pathways in vascular smooth muscle cells: upregulation in spontaneously hypertensive rats

E. Schiffrin, R. Touyz, F. Tabet, 2005, Journal of hypertension.

Downregulation of Renal TRPM7 and Increased Inflammation and Fibrosis in Aldosterone-Infused Mice: Effects of Magnesium

R. Touyz, A. Montezano, F. Tabet, 2008, Hypertension.

Differential regulation of Nox1, Nox2 and Nox4 in vascular smooth muscle cells from WKY and SHR.

R. Touyz, A. Briones, G. Callera, 2011, Journal of the American Society of Hypertension : JASH.

Expression of a Functionally Active gp91phox-Containing Neutrophil-Type NAD(P)H Oxidase in Smooth Muscle Cells From Human Resistance Arteries: Regulation by Angiotensin II

E. Schiffrin, R. Touyz, G. Yao, 2002, Circulation research.

microRNA-367-3p regulation of GPRC5A is suppressed in ischemic stroke

K. Vickers, A. Remaley, C. Sobey, 2020, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

MicroRNAs in the onset and development of cardiovascular disease.

K. Vickers, K. Rye, F. Tabet, 2014, Clinical science.

Biology, pathophysiology and current therapies that affect lipoprotein (a) levels.

F. Tabet, T. Rawther, 2019, Journal of molecular and cellular cardiology.

Transcoronary gradients of HDL-associated MicroRNAs in unstable coronary artery disease.

Sebastien A. Choteau, P. Barter, D. Celermajer, 2018, International journal of cardiology.

Chapter 30 – Reactive Oxygen Species, Oxidative Stress, and Vascular Biology in Hypertension

R. Touyz, F. Tabet, 2007 .

MicroRNA-223 coordinates cholesterol homeostasis

P. Sethupathy, K. Vickers, Brian T Palmisano, 2014, Proceedings of the National Academy of Sciences.

HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells

Praveen Sethupathy, P. Sethupathy, P. Barter, 2014, Nature Communications.

Differential Calcium Regulation by Hydrogen Peroxide and Superoxide in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats

E. Schiffrin, R. Touyz, F. Tabet, 2004, Journal of cardiovascular pharmacology.

Negative regulation of RhoA/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats

E. Schiffrin, R. Touyz, G. Yao, 2005, Journal of hypertension.

High-density lipoproteins induce miR-223-3p biogenesis and export from myeloid cells: Role of scavenger receptor BI-mediated lipid transfer.

K. Vickers, K. Rye, Wanying Zhu, 2019, Atherosclerosis.

High density lipoprotein-associated miRNA is increased following Roux-en-Y gastric bypass surgery for severe obesity.

K. Rye, K. Ong, Yifen Liu, 2021, Journal of lipid research.

Lipoprotein (a) and Coronary Artery Calcification: Prospective study assessing interactions with other risk factors.

R. McClelland, M. Cushman, M. Allison, 2021, Metabolism: clinical and experimental.

Redox‐dependent signalling by angiotensin II and vascular remodelling in hypertension

E. Schiffrin, R. Touyz, F. Tabet, 2003, Clinical and experimental pharmacology & physiology.

Apolipoprotein A‐l improves pancreatic β‐cell function independent of the ATP‐binding cassette transporters ABCA1 and ABCG1

P. Barter, K. Rye, B. Cochran, 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Reduction in PCSK9 levels induced by anacetrapib: an off-target effect?1

P. Barter, K. Rye, F. Tabet, 2015, Journal of Lipid Research.

Apolipoprotein A-I enhances insulin-dependent and insulin-independent glucose uptake by skeletal muscle

P. Barter, K. Rye, B. Cochran, 2019, Scientific Reports.

Redox-Sensitive Signaling by Angiotensin II Involves Oxidative Inactivation and Blunted Phosphorylation of Protein Tyrosine Phosphatase SHP-2 in Vascular Smooth Muscle Cells From SHR

Ying He, Ernesto L. Schiffrin, Rhian M. Touyz, 2008, Circulation research.

High-Density Lipoprotein-Associated miR-223 Is Altered after Diet-Induced Weight Loss in Overweight and Obese Males

Sebastien A. Choteau, P. Clifton, P. Barter, 2016, PloS one.

Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk.

P. Barter, D. Waters, J. Kastelein, 2017, Journal of clinical lipidology.

Apolipoprotein A-I Limits the Negative Effect of Tumor Necrosis Factor on Lymphangiogenesis

P. Barter, P. Tak, K. Rye, 2015, Arteriosclerosis, thrombosis, and vascular biology.

Lipoprotein (a) and the risk of elevated depressive symptoms: The Multi-Ethnic Study of Atherosclerosis.

M. Allison, K. Rye, K. Ong, 2020, Journal of psychiatric research.

High density lipoprotein-associated miRNA is increased following Roux-en-Y gastric bypass surgery for severe obesity

K. Rye, K. Ong, Yifen Liu, 2020, Journal of lipid research.

Apolipoprotein A-I improves pancreatic beta-cell function independent of the ATP-binding cassette transporters ABCA1 and ABCG1

K. Rye, B. Cochran, K. Ong, 2019 .